p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation

Molecular and Cellular Biology

Volumn 34, Issue 12, 2014, Pages 2121-2134

  Bai, Feng ^a   Chan, Ho Lam ^a   Smith, Matthew D ^c   Kiyokawa, Hiroaki ^d   Pei, Xin Hai ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2D; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; CDKN2D PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; TUMOR SUPPRESSOR PROTEIN;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; GENE DELETION; GENE MUTATION; GENE TARGETING; HISTOPATHOLOGY; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE; ANIMAL; ANIMAL EMBRYO; BODY WEIGHT; C57BL MOUSE; CARCINOGENESIS; CELL CYCLE S PHASE; EPITHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; FEMALE; FEMALE INFERTILITY; FIBROBLAST; GENE LOCUS; LUTEAL CELL; MALE; MALE INFERTILITY; METABOLISM; PANCREAS ISLET; PATHOLOGY; UDDER;

ANIMALS; BODY WEIGHT; CARCINOGENESIS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P19; DIABETES MELLITUS, EXPERIMENTAL; EMBRYO, MAMMALIAN; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE DELETION; GENETIC LOCI; INFERTILITY, FEMALE; INFERTILITY, MALE; ISLETS OF LANGERHANS; LUTEAL CELLS; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; PHENOTYPE; PITUITARY GLAND, ANTERIOR; S PHASE; TUMOR SUPPRESSOR PROTEINS;

EID: 84901361194     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01363-13     Document Type: Article

References (57)

1. Pei XH, Xiong Y. 2005. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24:2787-2795. http://dx.doi.org/10.1038/sj.onc.1208611.
2. Sherr CJ, McCormick F. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103-112. http://dx.doi.org/10.1016/S1535-6108(02)00102-2.
3. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330. http://dx.doi.org/10.1016/0092-8674(95)90385-2.
4. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300. http://dx.doi.org/10.1038/359295a0.
5. Lee Y-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294. http://dx.doi.org/10.1038/359288a0.
6. Nikitin AY, Juarez-Perez MI, Li S, Huang L, Lee WH. 1999. RBmediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb_/_ mice. Proc. Natl. Acad. Sci. U. S. A. 96: 3916-3921. http://dx.doi.org/10.1073/pnas.96.7.3916.
7. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13:4251-4259.
8. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557. http://dx.doi.org/10.1038/377552a0.
9. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684. http://dx.doi.org/10.1016/0092-8674(95)90039-X.
10. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413:83-86. http://dx.doi.org/10.1038/35092584.
11. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C, Barbacid M. 2000. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19:3496-3506. http://dx.doi.org/10.1093/emboj/19.13.3496.
12. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413:86-91. http://dx.doi.org/10.1038/35092592.
13. Zhang P, Liegeois N, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158. http://dx.doi.org/10.1038/387151a0.
14. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744. http://dx.doi.org/10.1016/S0092-8674(00)81239-8.
15. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y. 1998. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12:2899-2911. http://dx.doi.org/10.1101/gad.12.18.2899.
16. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732. http://dx.doi.org/10.1016/S0092-8674(00)81238-6.
17. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720. http://dx.doi.org/10.1016/S0092-8674(00)81237-4.
18. Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, Pollard JW, Sherr CJ, Cohen PE, Roussel MF. 2001. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d). Mol. Cell. Biol. 21:3244-3255. http://dx.doi.org/10.1128/MCB.21.9.3244-3255.2001.
19. Thullberg M, Bartkova J, Khan S, Hansen K, Ronnstrand L, Lukas J, Strauss M, Bartek J. 2000. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. FEBS Lett. 470:161-166. http://dx.doi.org/10.1016/S0014-5793(00)01307-7.
20. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. 2000. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol. Cell. Biol. 20:6147-6158. http://dx.doi.org/10.1128/MCB.20.16.6147-6158.2000.
21. Pei XH, Bai F, Tsutsui T, Kiyokawa H, Xiong Y. 2004. Genetic evidence for functional dependency of p18Ink4c on Cdk4. Mol. Cell. Biol. 24:6653- 6664. http://dx.doi.org/10.1128/MCB.24.15.6653-6664.2004.
22. Ramsey MR, Krishnamurthy J, Pei XH, Torrice C, Lin W, Carrasco DR, Ligon KL, Xiong Y, Sharpless NE. 2007. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Res. 67:4732-4741. http://dx.doi.org/10.1158/0008-5472.CAN-06-3437.
23. Ruas M, Peters G. 1998. The p16INK4a/CDK2A tumor suppresor and its relatives. Biochim. Biophys. Acta 1378:F115-F177.
24. Zindy F, Quelle DE, Roussel MF, Sherr CJ. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203-211. http://dx.doi.org/10.1038/sj.onc.1201178.
25. Morishita A, Gong J, Deguchi A, Tani J, Miyoshi H, Yoshida H, Himoto T, Yoneyama H, Mori H, Kato K, Kurokohchi K, Deguchi K, Izuishi K, Suzuki Y, Kushida Y, Haba R, Iwama H, Watanabe S, D'Armiento J, Masaki T. 2011. Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival. Oncol. Rep. 26:1363-1368. http://dx.doi.org/10.3892/or.2011.1452.
26. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J. 2000. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 19:4146-4150. http://dx.doi.org/10.1038/sj.onc.1203769.
27. Buchold GM, Magyar PL, O'Brien DA. 2007. Mice lacking cyclindependent kinase inhibitor p19Ink4d show strain-specific effects on male reproduction. Mol. Reprod. Dev. 74:1008-1020. http://dx.doi.org/10.1002/mrd.20715.
28. Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF. 2000. INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 20:372-378. http://dx.doi.org/10.1128/MCB.20.1.372-378.2000.
29. Asa SL, Ezzat S. 2002. The pathogenesis of pituitary tumours. Nat. Rev. Cancer 2:836-849. http://dx.doi.org/10.1038/nrc926.
30. Bamberger CM, Fehn M, Bamberger AM, Ludecke DK, Beil FU, Saeger W, Schulte HM. 1999. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas. Eur. J. Endocrinol. 140:250- 255. http://dx.doi.org/10.1530/eje.0.1400250.
31. Hossain MG, Iwata T, Mizusawa N, Qian ZR, Shima SW, Okutsu T, Yamada S, Sano T, Yoshimoto K. 2009. Expression of p18(INK4C) is down-regulated in human pituitary adenomas. Endocr. Pathol. 20:114- 121. http://dx.doi.org/10.1007/s12022-009-9076-0.
32. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG, Grossman AB. 1999. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J. Clin. Endocrinol. Metab. 84:3823-3830. http://dx.doi.org/10.1210/jc.84.10.3823.
33. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D. 1995. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res. 55:1613-1616.
34. Quereda V, Malumbres M. 2009. Cell cycle control of pituitary development and disease. J. Mol. Endocrinol. 42:75-86. http://dx.doi.org/10.1677/JME-08-0146.
35. Woloschak M, Yu A, Post KD. 1997. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol. Carcinog. 19:221-224. http://dx.doi.org/10.1002/(SICI)1098-2744(199708)19:4<221::AID-MC1>3.0.CO;2-F
36. Jirawatnotai S, Aziyu A, Osmundson EC, Moons DS, Zou X, Kineman RD, Kiyokawa H. 2004. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J. Biol. Chem. 279:51100-51106. http://dx.doi.org/10.1074/jbc.M409080200.
37. Moons DS, Jirawatnotai S, Parlow AF, Gibori G, Kineman RD, Kiyokawa H. 2002. Pituitary hypoplasia and lactotroph dysfunction in mice deficient for cyclin-dependent kinase-4. Endocrinology 143:3001-3008. http://dx.doi.org/10.1210/en.143.8.3001.
38. Tsutsui T, Hesabi B, Moons DS, Pandolfi PA, Hansel KS, Koff A, Kiyokawa H. 1999. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity. Mol. Cell. Biol. 19:7011-7019.
39. Sotillo R, Dubus P, Martin J, de La Cueva E, Ortega S, Malumbres M, Barbacid M. 2001. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:6637-6647. http://dx.doi.org/10.1093/emboj/20.23.6637.
40. Buchold GM, Magyar PL, Arumugam R, Lee MM, O'Brien DA. 2007. p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis. Mol. Reprod. Dev. 74:997-1007. http://dx.doi.org/10.1002/mrd.20716.
41. Franklin DS, Xiong Y. 1996. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell 7:1587-1599. http://dx.doi.org/10.1091/mbc.7.10.1587.
42. Phelps DE, Xiong Y. 1998. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Cell Growth Differ. 9:595-610.
43. Xiong Y, Zhang H, Beach D. 1993. Subunit rearrangement of cyclindependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583. http://dx.doi.org/10.1101/gad.7.8.1572.
44. Pei XH, Bai F, Li Z, Smith MD, Whitewolf G, Jin R, Xiong Y. 2011. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Res. 71:2969-2977. http://dx.doi.org/10.1158/0008-5472.CAN-10-4300.
45. Jenkins CW, Xiong Y. 1995. Immunoprecipitation and immunoblotting in cell cycle studies, p 250-263. In PaganoM(ed), Cell cycle: material and methods. Springer-Verlag, New York, NY.
46. Burke JR, Hura GL, Rubin SM. 2012. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev. 26:1156-1166. http://dx.doi.org/10.1101/gad.189837.112.
47. Schmitz NM, Leibundgut K, Hirt A. 2004. MCM4 shares homology to a replication/DNA-binding domain in CTF and is contacted by pRb. Biochem. Biophys. Res. Commun. 317:779-786. http://dx.doi.org/10.1016/j.bbrc.2004.03.109.
48. Zarkowska T, Harlow SUE, Mittnacht S. 1997. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs. Oncogene 14: 249-254. http://dx.doi.org/10.1038/sj.onc.1200824.
49. Rane SG, Dubus P, Mettus R, Galvreath EJ, Boden G, Reddy EP, Barbacid M. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activatiion results in b-islet cell hyperplasia. Nat. Genet. 22:44-52. http://dx.doi.org/10.1038/8751.
50. Moons DS, Jirawatnotai S, Tsutsui T, Franks R, Parlow AF, Hales DB, Gibori G, Fazleabas AT, Kiyokawa H. 2002. Intact follicular maturation and defective luteal function in mice deficient for cyclin-dependent kinase- Endocrinology 143:647-654. http://dx.doi.org/10.1210/en.143.2.647.
51. Lee HJ, Ormandy CJ. 2012. Interplay between progesterone and prolactin in mammary development and implications for breast cancer. Mol. Cell. Endocrinol. 357:101-107. http://dx.doi.org/10.1016/j.mce.2011.09.020.
52. Reddy HK, Mettus RV, Rane SG, Grana X, Litvin J, Reddy EP. 2005. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Cancer Res. 65:10174-10178. http://dx.doi.org/10.1158/0008-5472.CAN-05-2639.
53. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee W-H, Lee EY-HP. 1994. Heterozygous Rb-1D20/_ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021- 1027.
54. Maandag EC, Van Der Valk M, Vlaar M, Feltkamp C, O'Brien J, Van Roon M, Van Der Lugt N, Berns A, Te Riele H. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:4260-4268.
55. Thullberg M, Bartek J, Lukas J. 2000. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle. Oncogene 19:2870-2875. http://dx.doi.org/10.1038/sj.onc.1203579.
56. Cameron DF, Murray FT, Drylie DD. 1985. Interstitial compartment pathology and spermatogenic disruption in testes from impotent diabetic men. Anat. Rec. 213:53-62. http://dx.doi.org/10.1002/ar.1092130108.
57. Murray FT, Cameron DF, Orth JM. 1983. Gonadal dysfunction in the spontaneously diabetic BB rat. Metabolism 32:141-147. http://dx.doi.org/10.1016/S0026-0495(83)80028-6.